Interaction between phytotherapy and oral anticancer agents: prospective study and literature review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interaction between phytotherapy and oral anticancer agents: prospective study and literature review
Authors
Keywords
-
Journal
MEDICAL ONCOLOGY
Volume 36, Issue 5, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-04-16
DOI
10.1007/s12032-019-1267-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib
- (2018) Gracia M. Amaya et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver
- (2018) Michael Murray et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Effects of ketoconazole on cyclophosphamide metabolism: evaluation of CYP3A4 inhibition effect using the in vitro and in vivo models
- (2018) Le Yang et al. EXPERIMENTAL ANIMALS
- Concurrent administration of anticancer chemotherapy drug and herbal medicine on the perspective of pharmacokinetics
- (2018) Yung-Yi Cheng et al. JOURNAL OF FOOD AND DRUG ANALYSIS
- Metabolic profiling of the anti-tumor drug regorafenib in mice
- (2018) Yi-Kun Wang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats
- (2018) Yan Zhang et al. Pharmacological Reports
- Mechanisms of mitochondrial toxicity of the kinase inhibitors ponatinib, regorafenib and sorafenib in human hepatic HepG2 cells
- (2018) Franziska Paech et al. TOXICOLOGY
- A metabolomic perspective of pazopanib-induced acute hepatotoxicity in mice
- (2018) Yi-Kun Wang et al. XENOBIOTICA
- Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1
- (2018) Saki Omote et al. Scientific Reports
- Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib
- (2018) Alicja Puszkiel et al. CLINICAL PHARMACOKINETICS
- Characterization of the breast cancer resistance protein (BCRP/ABCG2 ) in clear cell renal cell carcinoma
- (2018) Anna Reustle et al. INTERNATIONAL JOURNAL OF CANCER
- Development of a rapid risk evaluation tool for herbs/drugs interactions in cancer patients: a multicentric experience in south of France
- (2017) B. Pourroy et al. EUROPEAN JOURNAL OF CANCER CARE
- The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors
- (2017) Mark C. de Gooijer et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibitory Effect of Crizotinib on Creatinine Uptake by Renal Secretory Transporter OCT2
- (2017) Hiroshi Arakawa et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Potential Drug Interactions Mediated by Renal Organic Anion Transporter OATP4C1
- (2017) Toshihiro Sato et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cutaneous Toxicity Induced by Hibiscus Tea in a Patient Treated with Erlotinib
- (2017) Claire Jacquin-Porretaz et al. Journal of Thoracic Oncology
- Construction and verification of CYP3A5 gene polymorphisms using a Saccharomyces cerevisiae expression system to predict drug metabolism
- (2017) Yao Lu et al. Molecular Medicine Reports
- AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5′-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes
- (2017) Ju-Hyun Kim et al. MOLECULES
- Herb-Drug Interaction between the Traditional Hepatoprotective Formulation and Sorafenib on Hepatotoxicity, Histopathology and Pharmacokinetics in Rats
- (2017) Chin-Tsung Ting et al. MOLECULES
- Influence of CYP2C8 polymorphisms on imatinib steady-state trough level in chronic myeloid leukemia and gastrointestinal stromal tumor patients
- (2017) Michiel C. Verboom et al. Pharmacogenetics and Genomics
- Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia
- (2017) Natarajan Harivenkatesh et al. PHARMACOLOGICAL RESEARCH
- Is the clinical relevance of drug-food and drug-herb interactions limited to grapefruit juice and Saint-John’s Wort?
- (2017) Stéphane Mouly et al. PHARMACOLOGICAL RESEARCH
- Induction of CYP1A1 increases gefitinib-induced oxidative stress and apoptosis in A549 cells
- (2017) Dan-Dan Wang et al. TOXICOLOGY IN VITRO
- In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450
- (2017) Alex McCormick et al. XENOBIOTICA
- Interactions of crizotinib and gefitinib with organic anion-transporting polypeptides (OATP)1B1, OATP1B3 and OATP2B1: gefitinib shows contradictory interaction with OATP1B3
- (2017) Toshihiro Sato et al. XENOBIOTICA
- Substrate-dependent effects of molecular-targeted anticancer agents on activity of organic anion transporting polypeptide 1B1
- (2017) Hiroyoshi Koide et al. XENOBIOTICA
- Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro
- (2017) Ping Fang et al. Drug Design Development and Therapy
- Tumor Thermal Ablation Enhancement by Micromaterials
- (2017) Fan Zhao et al. Current Drug Delivery
- Extracts of Immature Orange (Aurantii fructus immaturus) and Citrus Unshiu Peel (Citri unshiu pericarpium) Induce P-Glycoprotein and Cytochrome P450 3A4 Expression via Upregulation of Pregnane X Receptor
- (2017) Naoto Okada et al. Frontiers in Pharmacology
- Severe sunitinib-induced myelosuppression in a patient with a CYP 3A4 polymorphism
- (2017) Nirav D Patel et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Inadequate response to imatinib treatment in chronic myeloid leukemia due to a drug interaction with phenytoin
- (2017) S Osorio et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Characteristics, chemical compositions and biological activities of propolis from Al-Bahah, Saudi Arabia
- (2017) Yasser A. Elnakady et al. Scientific Reports
- Olaparib for the treatment of BRCA-mutated advanced ovarian cancer
- (2016) M. Munroe et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Phyto-anesthetics: A mini-review on herb–anesthesia drug interactions
- (2016) Sepideh Vahabi et al. BIOMEDICINE & PHARMACOTHERAPY
- Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells
- (2016) Kewei Ren et al. BIOMEDICINE & PHARMACOTHERAPY
- Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer
- (2016) Anubha Gupta et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A clinical drug–drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor on the pharmacokinetics of vismodegib
- (2016) Vikram Malhi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib
- (2016) Steven A. Lacy et al. CLINICAL PHARMACOKINETICS
- Clinical Pharmacokinetics and Pharmacodynamics of Afatinib
- (2016) Sven Wind et al. CLINICAL PHARMACOKINETICS
- Evaluation of Cytochrome P450 3A4-Mediated Drug–Drug Interaction Potential for Cobimetinib Using Physiologically Based Pharmacokinetic Modeling and Simulation
- (2016) Nageshwar R. Budha et al. CLINICAL PHARMACOKINETICS
- Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies
- (2016) Luc Dirix et al. CLINICAL THERAPEUTICS
- Pharmacokinetic model analysis of interaction between phenytoin and capecitabine
- (2016) Shohei Miyazaki et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Propolis extracts from the northern region of Thailand suppress cancer cell growth through induction of apoptosis pathways
- (2016) Supakit Khacha-ananda et al. INVESTIGATIONAL NEW DRUGS
- Physiologically Based Pharmacokinetic Modeling of Palbociclib
- (2016) Yanke Yu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo
- (2016) Z. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Osimertinib (AZD9291) Attenuates the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCB1 in Vitro
- (2016) Sung-Han Hsiao et al. MOLECULAR PHARMACEUTICS
- Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells
- (2016) Xiao-Yu Zhang et al. MOLECULES
- Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin
- (2016) C. Sauzay et al. PHARMACOLOGICAL RESEARCH
- In Vivo Cytochrome P450 3A Isoenzyme Activity and Pharmacokinetics of Imatinib in Relation to Therapeutic Outcome in Patients With Chronic Myeloid Leukemia
- (2016) Karin Skoglund et al. THERAPEUTIC DRUG MONITORING
- Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transport
- (2016) Martin Michaelis et al. Oncotarget
- RSK1 protects P-glycoprotein/ABCB1 against ubiquitin–proteasomal degradation by downregulating the ubiquitin-conjugating enzyme E2 R1
- (2016) Kazuhiro Katayama et al. Scientific Reports
- The Effect of Natural Health Products and Traditional Medicines on the Activity of Human Hepatic Microsomal-Mediated Metabolism of Oseltamivir
- (2016) Rui Liu et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Cranberry Juice Ingestion and Clinical Drug-Drug Interaction Potentials; Review of Case Studies and Perspectives
- (2016) Nuggehally R Srinivas JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Antimicrobial and P450 Inhibitory Properties of Common Functional Foods
- (2016) San Nguyen et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions
- (2015) R. W. F. van Leeuwen et al. ANNALS OF ONCOLOGY
- Regorafenib Is Transported by the Organic Anion Transporter 1B1 and the Multidrug Resistance Protein 2
- (2015) Hiroki Ohya et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Inhibitory effect of Curcuma purpurascens BI. rhizome on HT-29 colon cancer cells through mitochondrial-dependent apoptosis pathway
- (2015) Elham Rouhollahi et al. BMC Complementary and Alternative Medicine
- Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals
- (2015) Eran Ben-Arye et al. CANCER
- Activation Status of the Pregnane X Receptor Influences Vemurafenib Availability in Humanized Mouse Models
- (2015) A. Kenneth MacLeod et al. CANCER RESEARCH
- Clinical Pharmacokinetic Studies of Enzalutamide
- (2015) Jacqueline A. Gibbons et al. CLINICAL PHARMACOKINETICS
- The effects of ketoconazole and rifampin on the single-dose pharmacokinetics of crizotinib in healthy subjects
- (2015) Huiping Xu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Metabolic behavior prediction of pazopanib by cytochrome P450 (CYP) 3A4 by molecular docking
- (2015) Xing-Jie Liu et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Effect of Ginkgo Leaf Tablets on the Pharmacokinetics of Amlodipine in Rats
- (2015) Rong Wang et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Pharmacokinetic Interactions of Herbs with Cytochrome P450 and P-Glycoprotein
- (2015) Hyun-Jong Cho et al. Evidence-based Complementary and Alternative Medicine
- Pharmacokinetics of crizotinib in NSCLC patients
- (2015) Gerhard Hamilton et al. Expert Opinion on Drug Metabolism & Toxicology
- Characterization and biological properties of NanoCUR formulation and its effect on major human cytochrome P450 enzymes
- (2015) Suhaili Shamsi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4/6 inhibitor palbociclib
- (2015) Mark C. de Gooijer et al. INVESTIGATIONAL NEW DRUGS
- Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK
- (2015) Linh Nguyen et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Brain and Testis Accumulation of Regorafenib is Restricted by Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1)
- (2015) Anita Kort et al. PHARMACEUTICAL RESEARCH
- Effect of the CYP3A5 and ABCB1 genotype on exposure, clinical response and manifestation of toxicities from sunitinib in Asian patients
- (2015) Y L Teo et al. PHARMACOGENOMICS JOURNAL
- Pharmacokinetic Herb-Drug Interaction between Essential Oil of Aniseed (Pimpinella anisumL., Apiaceae) and Acetaminophen and Caffeine: A Potential Risk for Clinical Practice
- (2015) Isidora Samojlik et al. PHYTOTHERAPY RESEARCH
- Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions
- (2015) Navjotsingh Pabla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Influence of Annona muricata (soursop) on biodistribution of radiopharmaceuticals in rats
- (2015) Cecília Maria de Carvalho Xavier Holanda et al. Acta Cirurgica Brasileira
- Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation
- (2015) Ibrahim El-Serafi et al. PLoS One
- Carvacrol ameliorates the Ppar-Α and Cytochrome P450 Expression on D-Galactosamine Induced Hepatotoxicity Rats
- (2014) B Aristatile et al. African Journal of Traditional Complementary and Alternative Medicines
- Is oral chemotherapy prescription safe for patients? A cross-sectional survey
- (2014) A. Bourmaud et al. ANNALS OF ONCOLOGY
- Effect of erlotinib on CYP3A activity, evaluated in vitro and by dual probes in patients with cancer
- (2014) Hilary Calvert et al. ANTI-CANCER DRUGS
- The multikinase inhibitor axitinib is a potent inhibitor of human CYP1A2
- (2014) Rui Gu et al. BIOCHEMICAL PHARMACOLOGY
- Liver toxicity during temozolomide chemotherapy caused by Chinese herbs
- (2014) Thomas Melchardt et al. BMC Complementary and Alternative Medicine
- The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects
- (2014) Marta Hamilton et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment
- (2014) David Schnell et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Effects of triptolide on the pharmacokinetics of cyclophosphamide in rats: A possible role of CytochromeP3A4 inhibition
- (2014) Xi-feng Zhang et al. Chinese Journal of Integrative Medicine
- P-Glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain and Blood Disposition of the mTOR Inhibitor Everolimus (Afinitor) in Mice
- (2014) S. C. Tang et al. CLINICAL CANCER RESEARCH
- Pharmacokinetic Drug Interactions of Afatinib with Rifampicin and Ritonavir
- (2014) Sven Wind et al. CLINICAL DRUG INVESTIGATION
- Effect of Rifampicin on the Pharmacokinetics of Lenvatinib in Healthy Adults
- (2014) Robert C. Shumaker et al. CLINICAL DRUG INVESTIGATION
- Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine
- (2014) Susanne Johansson et al. CLINICAL PHARMACOKINETICS
- Impact of traditional African medicine on drug metabolism and transport
- (2014) Carlemi Calitz et al. Expert Opinion on Drug Metabolism & Toxicology
- Drug interactions with phytotherapeutics in oncology
- (2014) Walter Emil Haefeli et al. Expert Opinion on Drug Metabolism & Toxicology
- Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib
- (2014) A. Benjamin Suttle et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Alteration of anti-inflammatory activity ofHarpagophytum procumbens(devil's claw) extract after external metabolic activation with S9 mix
- (2014) Katarina Hostanska et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Herbal tea extracts inhibit Cytochrome P450 3A4 in vitro
- (2014) Sophie Dufay et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- The in-vitro effect of complementary and alternative medicines on cytochrome P450 2C9 activity
- (2014) Kim D. Mooiman et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Inhibitory effect of synthetic cannabinoids on CYP1A activity in mouse liver microsomes
- (2014) Takashi Ashino et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective
- (2014) Roelof W F van Leeuwen et al. LANCET ONCOLOGY
- Role of P-Glycoprotein on the Brain Penetration and Brain Pharmacodynamic Activity of the MEK Inhibitor Cobimetinib
- (2014) Edna F. Choo et al. MOLECULAR PHARMACEUTICS
- Oral chemotherapy prescription safety practices in Europe
- (2014) David Conde-Estévez et al. International Journal of Clinical Pharmacy
- Role of clinical pharmacists to prevent drug interactions in cancer outpatients: a single-centre experience
- (2014) Carmen Lopez-Martin et al. International Journal of Clinical Pharmacy
- Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies
- (2014) Yow-Wen Hsieh et al. Scientific Reports
- Oral Chemotherapy Food and Drug Interactions: A Comprehensive Review of the Literature
- (2014) Eve M. Segal et al. Journal of Oncology Practice
- Drug Interactions and the Pharmacist: Focus on Everolimus
- (2013) Jennifer A Grabowsky ANNALS OF PHARMACOTHERAPY
- Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs
- (2013) R W F van Leeuwen et al. BRITISH JOURNAL OF CANCER
- Potential drug–drug interactions at a referral hematology–oncology ward in Iran: a cross-sectional study
- (2013) Molouk Hadjibabaie et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb–drug interactions in cancer patients
- (2013) Andrew K.L. Goey et al. CANCER TREATMENT REVIEWS
- Contribution of OATP1B1 and OATP1B3 to the Disposition of Sorafenib and Sorafenib-Glucuronide
- (2013) E. I. Zimmerman et al. CLINICAL CANCER RESEARCH
- Clinical Pharmacology of Axitinib
- (2013) Ying Chen et al. CLINICAL PHARMACOKINETICS
- Gemfibrozil Impairs Imatinib Absorption and Inhibits the CYP2C8-Mediated Formation of Its Main Metabolite
- (2013) A M Filppula et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Drug interactions with solid tumour-targeted therapies
- (2013) Audrey Thomas-Schoemann et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Pharmacokinetic drug interactions involvingGinkgo biloba
- (2013) Matthias Unger DRUG METABOLISM REVIEWS
- Relationship between everolimus exposure and safety and efficacy: Meta-analysis of clinical trials in oncology
- (2013) Alain Ravaud et al. EUROPEAN JOURNAL OF CANCER
- Influence of the multidrug transporter P-glycoprotein on the intracellular pharmacokinetics of vandetanib
- (2013) C. Jovelet et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Clinical consequences of polypharmacy in elderly
- (2013) Robert L Maher et al. Expert Opinion On Drug Safety
- Inhibitory Effects of Spirulina platensis on Carcinogen-Activating Cytochrome P450 Isozymes and Potential for Drug Interactions
- (2013) Seda Savranoglu et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Effect of Chinese herbs on CYP3A4 activity and expression in vitro
- (2013) C. Lau et al. JOURNAL OF ETHNOPHARMACOLOGY
- Effects of aescin on cytochrome P450 enzymes in rats
- (2013) Yi Huang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes
- (2013) Shu-Yan Han et al. JOURNAL OF ETHNOPHARMACOLOGY
- Abiraterone inhibits 1α,25-dihydroxyvitamin D3 metabolism by CYP3A4 in human liver and intestine in vitro
- (2013) Subrata Deb et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- In vitroInhibition of Human CYP1A2, CYP2D6, and CYP3A4 by Six Herbs Commonly Used in Pregnancy
- (2013) Astrid Jordet Langhammer et al. PHYTOTHERAPY RESEARCH
- Pharmacokinetic Drug Interactions with Vandetanib during Coadministration with Rifampicin or Itraconazole
- (2013) Paul Martin et al. Drugs in research & development
- Survey of oral chemotherapy safety and adherence practices of hospitals in Spain
- (2013) David Conde-Estévez et al. International Journal of Clinical Pharmacy
- Herb-Drug Interaction of 50 Chinese Herbal Medicines on CYP3A4 Activity in Vitro and in Vivo
- (2012) Li-Heng Pao et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Effects of Astragalus polysaccharides on P-glycoprotein efflux pump function and protein expression in H22 hepatoma cells in vitro
- (2012) Qing E Tian et al. BMC Complementary and Alternative Medicine
- Herb-drug interactions: an overview of systematic reviews
- (2012) Paul Posadzki et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Drug Interactions with Herbal Medicines
- (2012) Shaojun Shi et al. CLINICAL PHARMACOKINETICS
- Study of the upregulation of the activity of cytochrome P450 3A isoforms by Astragalus injection and Astragalus granules in rats and in cells
- (2012) Yongli Zhang et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin
- (2012) C. Jovelet et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- PXR-mediated P-glycoprotein induction by small molecule tyrosine kinase inhibitors
- (2012) S. Harmsen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Combination therapy of Western drugs and herbal medicines: recent advances in understanding interactions involving metabolism and efflux
- (2012) Chrisna Gouws et al. Expert Opinion on Drug Metabolism & Toxicology
- The influence of essential oil of aniseed (Pimpinella anisum, L.) on drug effects on the central nervous system
- (2012) Isidora Samojlik et al. FITOTERAPIA
- Green Tea and Lung Cancer
- (2012) Heidi Fritz et al. INTEGRATIVE CANCER THERAPIES
- Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review
- (2012) H.-H. Tsai et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center
- (2012) T. Zeller et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Influences of processed rhubarbs on the activities of four CYP isozymes and the metabolism of saxagliptin in rats based on probe cocktail and pharmacokinetics approaches
- (2012) Jingwen Gao et al. JOURNAL OF ETHNOPHARMACOLOGY
- Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data
- (2012) Angelo A. Izzo MEDICAL PRINCIPLES AND PRACTICE
- Oral Availability and Brain Penetration of the B-RAFV600E Inhibitor Vemurafenib Can Be Enhanced by the P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Inhibitor Elacridar
- (2012) Selvi Durmus et al. MOLECULAR PHARMACEUTICS
- Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms
- (2012) Penelope M.Y. Or et al. PHYTOMEDICINE
- In vitroInhibition of CYP3A4 by the Multiherbal Commercial Product Sambucus Force and its Main ConstituentsEchinacea purpureaandSambucus nigra
- (2012) Torstein Schrøder-Aasen et al. PHYTOTHERAPY RESEARCH
- Assessment of Extracts from Red Yeast Rice for Herb-Drug Interaction by in-vitro and in-vivo assays
- (2012) Wai To Fung et al. Scientific Reports
- Substrate-dependent modulation of the catalytic activity of CYP3A by erlotinib
- (2011) Pei-pei Dong et al. ACTA PHARMACOLOGICA SINICA
- Evaluation of metabolism-mediated herb-drug interactions
- (2011) Dong Hee Na et al. ARCHIVES OF PHARMACAL RESEARCH
- Effective Cytochrome P450 (CYP) Inhibitor Isolated from Thyme (Thymus saturoides) Purchased from a Japanese Market
- (2011) Zeineb BRAHMI et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Licorice extract increases cyclophosphamide teratogenicity by upregulating the expression of cytochrome P-450 2B mRNA
- (2011) Dongsun Park et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Afatinib pharmacokinetics and metabolism after oral administration to healthy male volunteers
- (2011) Peter Stopfer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors
- (2011) Paola Di Gion et al. CLINICAL PHARMACOKINETICS
- Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?
- (2011) J. S. McLay et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- How Many Cancer Patients Use Complementary and Alternative Medicine
- (2011) Markus Horneber et al. INTEGRATIVE CANCER THERAPIES
- Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: Implication for clinical drug–drug interactions
- (2011) Jin-Hui Song et al. JOURNAL OF BIOSCIENCES
- Isolation of gentiopicroside from Gentianae Radix and its pharmacokinetics on liver ischemia/reperfusion rats
- (2011) Wan-Ling Chang-Liao et al. JOURNAL OF ETHNOPHARMACOLOGY
- In vitro antiplasmodial activity of indole alkaloids from the stem bark of Geissospermum vellosii
- (2011) Flaubert Mbeunkui et al. JOURNAL OF ETHNOPHARMACOLOGY
- Assessment of Extracts from Mistletoe (Viscum album) for Herb-Drug Interaction by Inhibition and Induction of Cytochrome P450 Activities
- (2011) Johannes Doehmer et al. PHYTOTHERAPY RESEARCH
- Exploring the Possible Metabolism Mediated Interaction of Glycyrrhiza glabra Extract with CYP3A4 and CYP2D6
- (2011) Subrata Pandit et al. PHYTOTHERAPY RESEARCH
- Imatinib and Panax Ginseng: A Potential Interaction Resulting in Liver Toxicity
- (2010) Naveen Bilgi et al. ANNALS OF PHARMACOTHERAPY
- Potential drug interactions in elderly cancer patients
- (2010) V. Girre et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Herbal Interactions with Anticancer Drugs: Mechanistic and Clinical Considerations
- (2010) An-Kui Yang et al. CURRENT MEDICINAL CHEMISTRY
- Deglycosylated Ginsenosides Are More Potent Inducers of CYP1A1, CYP1A2 and CYP3A4 Expression in HepG2 Cells than Glycosylated Ginsenosides
- (2010) Miao Hao et al. Drug Metabolism and Pharmacokinetics
- Herb–drug pharmacokinetic interactions reviewed
- (2010) Clemence Tarirai et al. Expert Opinion on Drug Metabolism & Toxicology
- Effects of herbal products on the metabolism and transport of anticancer agents
- (2010) Shu-Ming He et al. Expert Opinion on Drug Metabolism & Toxicology
- Evidence-Based Management of Herb-Drug Interaction in Cancer Chemotherapy
- (2010) Chung-Wah Cheng et al. Explore-The Journal of Science and Healing
- Metabolism mediated interaction of α-asarone and Acorus calamus with CYP3A4 and CYP2D6
- (2010) Subrata Pandit et al. FITOTERAPIA
- Acute Hepatotoxicity After Ingestion of Morinda citrifolia (Noni Berry) Juice in a 14-year-old Boy
- (2010) Elizabeth L Yu et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Drug Interaction Between Complementary Herbal Medicines and Gefitinib
- (2010) Sung-Wook Hwang et al. Journal of Thoracic Oncology
- Potential drug–drug interactions between anti-cancer agents and community pharmacy dispensed drugs
- (2010) Marsha L. Voll et al. PHARMACY WORLD & SCIENCE
- Isolation and Identification of Intestinal CYP3A Inhibitors from Cranberry (Vaccinium macrocarpon) Using Human Intestinal Microsomes
- (2010) Eunkyung Kim et al. PLANTA MEDICA
- Effects of Herbal Supplements on Drug Glucuronidation. Review of Clinical, Animal, andIn VitroStudies
- (2010) Mohamed-Eslam Mohamed et al. PLANTA MEDICA
- Herb–Drug Interactions with St John’s Wort (Hypericum perforatum): an Update on Clinical Observations
- (2009) Francesca Borrelli et al. AAPS Journal
- Drug interactions in oncology: how common are they?
- (2009) R. P. Riechelmann et al. ANNALS OF ONCOLOGY
- Trade Herbal Products and Induction of CYP2C19 and CYP2E1 in Cultured Human Hepatocytes
- (2009) Bent H. Hellum et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats
- (2009) Joong-Hwa Chung et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Interactions Between Herbal Medicines and Prescribed Drugs
- (2009) Angelo A. Izzo et al. DRUGS
- Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen
- (2009) Zeynep S. Teksin et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein
- (2009) Nadia Romiti et al. PHYTOMEDICINE
- Drug interaction potential of the seed extract ofUrtica urensL. (dwarf Nettle)
- (2009) Hizlan H. Agus et al. PHYTOTHERAPY RESEARCH
- In vitroinhibition of CYP3A4 by herbal remedies frequently used by cancer patients
- (2009) Silje Engdal et al. PHYTOTHERAPY RESEARCH
- An onco-informatics database for anticancer drug interactions with complementary and alternative medicines used in cancer treatment and supportive care: an overview of the OncoRx project
- (2009) Kevin Yi-Lwern Yap et al. SUPPORTIVE CARE IN CANCER
- In vitro Inhibition of CYP3A4 Metabolism and P-Glycoprotein-Mediated Transport by Trade Herbal Products
- (2008) Bent H. Hellum et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Inhibitory Effects of Fruit Juices on Cytochrome P450 2C9 Activityin Vitro
- (2008) Muneaki HIDAKA et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Use of complementary therapies by Australian women with breast cancer
- (2008) T. Kremser et al. BREAST
- The recovery time-course of CYP3A after induction by St John's wort administration
- (2008) Hiromitsu Imai et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide
- (2008) H Xu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals
- (2008) Tomohiro Nabekura et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- How the public is being misled about complementary/alternative medicine
- (2008) Edzard Ernst JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
- Gauging the clinical significance of P‐glycoprotein‐mediated herb‐drug interactions: Comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics
- (2008) Bill J. Gurley et al. MOLECULAR NUTRITION & FOOD RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now